Skip to content

Profound Medical PROF Interest coverage

Interest coverage at other companies

TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
-4.9×-1.2×
Globus Medical logo
Globus MedicalGMED
42.4×

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Calculated from Profound Medical’s reported figures.

Based on trailing twelve months.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's interest coverage?
Profound Medical (PROF) reported interest coverage of -38× in Q1 2026.
How has Profound Medical's interest coverage changed year-over-year?
Profound Medical's interest coverage decreased by 48.5% year-over-year, from -25.6× to -38×.
What is the long-term trend for Profound Medical's interest coverage?
Over 2 years (2023 to 2025), Profound Medical's interest coverage has grown at a 2.1% compound annual growth rate (CAGR), from -37× to -38.6×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.